TipRanks
55% OFF
PC:IMCHE

ImCheck Therapeutics

31 chemin Joseph Aiguier CS 70071 Marseille, Provence-Alpes-Cote d'Azur 13009, FRhttps://imchecktherapeutics.com/Therapeutics

ImCheck Therapeutics is a clinical-stage biotechnology company focused on developing immunotherapies that modulate innate immune checkpoints to treat cancer. The company advances antibody-based therapeutic programs designed to activate or reprogram innate immune cells and to be used alone or in combination with established oncology treatments. ImCheck also integrates translational biomarker strategies to inform patient selection and clinical development.

Leadership & Board

Current Number of Employees
44
Current LinkedIn Followers
11,817

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$22M
Total Funding Rounds
1
Latest Funding Amount
$22M
Latest Funding Round
Investment
Post-Money Valuation
―

Employee Trend

ImCheck Therapeutics had 44 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

44Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Apr 27, 2026May 11, 2026May 25, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Social Trend

ImCheck Therapeutics had 11,817 followers as of October 12, 2026. The number of followers increased by 13 (0.11%) week-over-week.

11,817Latest Followers Count
13(0.11%)Week-Over-Week Change
05,00010,00015,00020,000Apr 27, 2026May 11, 2026May 25, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Sep 29, 2024Investment$22.40M―

Investors

Investor NameFunding Round
France 2030Investment

Similar Companies

A snapshot of private companies similar to ImCheck Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis